STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies

Rare disease advocates applauded the FDA's move to speed access to treatments.

How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →

Every article behind this summary — 1 article from 1 outlet